Collection's Items (Sorted by Submit Date in Descending order): 901 to 920 of 960
Issue Date | Title | Author(s) |
2014-05 | Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences | Mahesh, R. |
2014-09 | Antidepressant-like effect of a novel 5-HT3 receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests | Mahesh, R. |
2013-06 | 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carboxylic acids: Novel 5-HT3 receptor antagonists with anxiolytic-like activity in rodent behavioral models | Mahesh, R. |
2016-09 | Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats | Mahesh, R. |
2015 | Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery | Mahesh, R. |
2010-01 | Anti-Depressant-Like Activity of Mucuna Pruriens; A Traditional Indian Herb in Rodent Models of Depression | Mahesh, R.; Jhadav, Hemant R. |
2011-01 | Quinoxalin-2-carboxamides: synthesis and pharmacological evaluation as serotonin type-3 (5-HT3) receptor antagonists | Mahesh, R. |
2012-09 | Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT3 receptor antagonist: An investigation in behaviour-based rodent models of depression | Mahesh, R. |
2013-07 | Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats | Mahesh, R. |
2013-12 | Design, Synthesis and Evaluation of Antidepressant Activity of Novel 2-Methoxy 1, 8 Naphthyridine 3-Carboxamides as 5-HT3 Receptor Antagonists | Mahesh, R. |
2013 | Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests | Mahesh, R. |
2014-11 | Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety | Mahesh, R. |
2014-06 | Design, Synthesis, and Pharmacological Evaluation of Novel 2-(4-substituted piperazin-1-yl)1, 8 Naphthyridine 3-Carboxylic Acids as 5-HT3 Receptor Antagonists for the Management of Depression | Mahesh, R. |
2014-10 | QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: An approach based on behavioral and biochemical investigations | Mahesh, R. |
2017-12 | Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model | Mahesh, R. |
2010-05 | Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats | Mahesh, R. |
2016-01 | A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2- carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system | Mahesh, R. |
2012-12 | Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n) | Mahesh, R. |
2014 | Anti-anxiety effect of a novel 5-HT3 receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice | Mahesh, R. |
2013-11 | QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice | Mahesh, R. |
Collection's Items (Sorted by Submit Date in Descending order): 901 to 920 of 960